Why the study?
What is the epidemiology and mechanism of increased cardiovascular risk in patients with rheumatoid arthritis?
Population
Patients with rheumatoid arthritis (RA)
Design
Review
Authors
Loading...
CV risk evaluation in RA warrants heightened vigilance for inflammatory drivers; leaves open whether targeting them improves survival beyond traditional factors.
What is the epidemiology and mechanism of increased cardiovascular risk in patients with rheumatoid arthritis?
This review highlights that cardiovascular disease is the leading cause of mortality in rheumatoid arthritis, emphasizing the potential role of novel inflammatory risk factors in accelerating coronary heart disease.
Nicola Goodson (2002) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: